Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial
- PMID: 24866862
- PMCID: PMC4266388
- DOI: 10.1001/jama.2014.5616
Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial
Abstract
Importance: In older adults reduced mobility is common and is an independent risk factor for morbidity, hospitalization, disability, and mortality. Limited evidence suggests that physical activity may help prevent mobility disability; however, there are no definitive clinical trials examining whether physical activity prevents or delays mobility disability.
Objective: To test the hypothesis that a long-term structured physical activity program is more effective than a health education program (also referred to as a successful aging program) in reducing the risk of major mobility disability.
Design, setting, and participants: The Lifestyle Interventions and Independence for Elders (LIFE) study was a multicenter, randomized trial that enrolled participants between February 2010 and December 2011, who participated for an average of 2.6 years. Follow-up ended in December 2013. Outcome assessors were blinded to the intervention assignment. Participants were recruited from urban, suburban, and rural communities at 8 centers throughout the United States. We randomized a volunteer sample of 1635 sedentary men and women aged 70 to 89 years who had physical limitations, defined as a score on the Short Physical Performance Battery of 9 or below, but were able to walk 400 m.
Interventions: Participants were randomized to a structured, moderate-intensity physical activity program (n = 818) conducted in a center (twice/wk) and at home (3-4 times/wk) that included aerobic, resistance, and flexibility training activities or to a health education program (n = 817) consisting of workshops on topics relevant to older adults and upper extremity stretching exercises.
Main outcomes and measures: The primary outcome was major mobility disability objectively defined by loss of ability to walk 400 m.
Results: Incident major mobility disability occurred in 30.1% (246 participants) of the physical activity group and 35.5% (290 participants) of the health education group (hazard ratio [HR], 0.82 [95% CI, 0.69-0.98], P = .03).Persistent mobility disability was experienced by 120 participants (14.7%) in the physical activity group and 162 participants (19.8%) in the health education group (HR, 0.72 [95% CI, 0.57-0.91]; P = .006). Serious adverse events were reported by 404 participants (49.4%) in the physical activity group and 373 participants (45.7%) in the health education group (risk ratio, 1.08 [95% CI, 0.98-1.20]).
Conclusions and relevance: A structured, moderate-intensity physical activity program compared with a health education program reduced major mobility disability over 2.6 years among older adults at risk for disability. These findings suggest mobility benefit from such a program in vulnerable older adults.
Trial registration: clinicaltrials.gov Identifier: NCT01072500.
Figures





References
-
- The Older Population: 2010 Census Briefs. Washington, DC: U.S. Department of Commerce; 2012.
-
- Katz S, Branch LG, Branson MH, Papsidero JA, Beck JC, Greer DS. Active life expectancy. N Engl J Med. 1983;309:1218–1224. - PubMed
-
- Branch LG, Guralnik JM, Foley DJ, et al. Active life expectancy for 10,000 Caucasian men and women in three communities. J Gerontol. 1991;46:M145–50. - PubMed
-
- Lonergan ET, Krevans JR. A national agenda for research on aging. N Engl J Med. 1991;324:1825–1828. - PubMed
-
- Guralnik JM, LaCroix AZ, Abbott RD, et al. Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol. 1993;137:845–857. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- P30 AG024827/AG/NIA NIH HHS/United States
- UO1AG22376/AG/NIA NIH HHS/United States
- UL1 RR029890/RR/NCRR NIH HHS/United States
- UL1 TR000064/TR/NCATS NIH HHS/United States
- R01 HL121023/HL/NHLBI NIH HHS/United States
- P30 AG031679/AG/NIA NIH HHS/United States
- 3U01AG022376-05A2S/AG/NIA NIH HHS/United States
- 1R24HD065688-01A1/HD/NICHD NIH HHS/United States
- P30AG021342/AG/NIA NIH HHS/United States
- UL1 TR001085/TR/NCATS NIH HHS/United States
- R24 HD065688/HD/NICHD NIH HHS/United States
- U54RR025208/RR/NCRR NIH HHS/United States
- U01 AG022376/AG/NIA NIH HHS/United States
- P30 AG021332/AG/NIA NIH HHS/United States
- P30 AG028740/AG/NIA NIH HHS/United States
- P30 AG021342/AG/NIA NIH HHS/United States
- UL1 RR025744/RR/NCRR NIH HHS/United States
- UL1 TR000142/TR/NCATS NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- K07AG3587/AG/NIA NIH HHS/United States
- 1 P30 AG21332/AG/NIA NIH HHS/United States
- 1P30AG031679/AG/NIA NIH HHS/United States
- 1 P30 AG028740/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical